SOPHIA ANTIPOLIS, France – January 19, 2026 │ The mRNA therapeutics landscape maintained strong momentum in Q4 2025 with 200 new patent applications and a record 125 granted patents across key jurisdictions (US, EP, JP, KR). This quarter highlights the expanding global reach of RNA-based technologies and shifts in strategic IP positioning. Therapeutic mRNA patent[…]
SOPHIA ANTIPOLIS, France – January 13, 2026 │ KnowMade is pleased to announce the availability of its Q4 2025 solid-state batteries intellectual property monitoring update, delivering a comprehensive and up-to-date analysis of patenting activity worldwide. This quarterly release provides decision-makers with strategic insights into technology trends, competitive dynamics, and emerging innovators shaping the future of[…]
SOPHIA ANTIPOLIS, France – December 18, 2025 │ KnowMade’s Patent Analyst Elodie Bovier, PhD, explores patent trends shaping mRNA delivery in ONdrugDelivery’s Dec 2025 issue. KnowMade maps innovation in mRNA delivery in new article KnowMade is proud to announce the publication of its latest contribution in the December 2025 issue of ONdrugDelivery, titled “Mapping Innovation[…]
SOPHIA ANTIPOLIS, France – December 16, 2025 │ KnowMade, a leading provider of patent analysis services, is pleased to present its latest report, Cancer & Antibody Conjugates Patent Landscape Analysis 2025. The comprehensive report offers a thorough examination of the competitive landscape of Antibody Conjugates (antibody-drug conjugates, or ADC, and radioimmunoconjugates) for cancer treatment from[…]